The genetic basis of thyroid autoimmunity

Thyroid

Volumn 17, Issue 10, 2007, Pages 949-961

  Jacobson, Eric M ^a   Tomer, Yaron ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE ANTIGEN; THYROGLOBULIN; THYROTROPIN RECEPTOR;

AUTOIMMUNE DISEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE PREDISPOSITION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; THYROID DISEASE;

ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION; AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; THYROID GLAND;

EID: 35948953900     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0153     Document Type: Review

References (166)

1. Davies TF 2000 Graves' diseases: pathogenesis. In: Braverman LE, Utiger RD (eds) Werner & Ingbar's the Thyroid: A Fundamental and Clinical Text. Lippincott Williams & Wilkins, Philadelphia, pp 518-530.
2. Weetman AP 2000 Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) Werner & Ingbar's the Thyroid: A Fundamental and Clinical Text. Lippincott Williams & Wilkins, Philadelphia, pp 721-732.
3. Stagnaro-Green A 2002 Clinical review 152: postpartum thyroiditis. J Clin Endocrinol Metab 87:4042-4047.
4. Roti E, Uberti E 2002 Post-partum thyroiditis - a clinical update. Eur J Endocrinol 146:275-279.
5. Muller AF, Drexhage HA, Berghout A 2001 Postpartum thyroiditis and autoimmune thyroiditis in women of child-bearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 22:605-630.
6. Mandac JC, Chaudhry S, Sherman KE, Tomer Y 2006 The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 43:661-672.
7. Obermayer-Straub P, Manns MP 1998 Autoimmune polyglandular syndromes. Baillieres Clin Gastroenterol 12:293-315.
8. Betterle C, Volpato M, Greggio AN, Presotto F 1996 Type 2 polyglandular autoimmune disease (Schmidt's syndrome). Baillieres Clin Gastroenterol J Pediatr Endocrinol Metab 9 Suppl 1:113-123.
9. Hall R, Dingle PR, Roberts DF 1972 Thyroid antibodies: a study of first degree relatives. Clin Genet 3:319-324.
10. Tomer Y, Davies TF 2003 Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24:694-717.
11. Martin L 1945 The heredity and familial aspects of exophthalmic goitre and nodular goitre. Q J Med 14:207-219.
12. Hall R, Stanbury JB 1967 Familial studies of autoimmune thyroiditis. Clin Exp Immunol 2:719-725.
13. Villanueva RB, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, Maclaren N, Sun ZS, Zhang DM, Tucci S, Davies TF 2000 Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for ctla-4 and evidence for an environmental etiology. Thyroid 10:791-798.
14. Risch N 1990 Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241.
15. Villanueva R, Greenberg DA, Davies TF, Tomer Y 2003 Sibling recurrence risk in autoimmune thyroid disease. Thyroid 13:761-764.
16. Brix TH, Christensen K, Holm NV, Harvald B, Hegedus L 1998 A population-based study of Graves' diseases in Danish twins. Clin Endocrinol (Oxf) 48:397-400.
17. Brix TH, Kyvik KO, Christensen K, Hegedus L 2001 Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86:930-934.
18. Ringold DA, Nicoloff JT, Kesler M, Davis H, Hamilton A, Mack T 2002 Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid 12:647-653.
19. Brix TH, Kyvik KO, Hegedus L 2000 A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85:536-539.
20. Phillips DI, Osmond C, Baird J, Huckle A, Rees-Smith B 2002 Is birthweight associated with thyroid autoimmunity? A study in twins. Thyroid 12:377-380.
21. Greenberg DA 1993 Linkage analysis of "necessary" loci versus "susceptibility" loci. Am J Hum Genet 52:135-143.
22. Ott J 1999 Analysis of Human Genetic Linkage, 3rd ed. Johns Hopkins University Press, Baltimore.
23. Lander E, Kruglyak L 1995 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247.
24. Woolf B 1955 On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
25. Hodge SE 1994 What association analysis can and cannot tell us about the genetics of complex disease. Am J Med Genet 54:318-323.
26. Davies JL, Kawauchi Y, Bennet ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Baln SC, Todd JA 1994 A genome-wide search for human type1 diabetes susceptibility genes. Nature 371:130-136.
27. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF 2003 Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736-747.
28. Glazier AM, Nadeau JH, Aitman TJ 2002 Finding genes that underlie complex traits. Science 298:2345-2349.
29. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P 2005 A haplotype map of the human genome. Nature 437:1299-1320.
30. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH 2006 A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-1463.
31. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, McDermott M, Sinha AA, Timmerman L, Steinman L 1988 A molecular basis for MHC class II-associated autoimmunity. Science 240:1003-1009.
32. Bech K, Lumholtz B, Nerup J, Thomsen M, Platz P, Ryder LP, Svejgaard A, Siersbaek-Nielsen K, Hansen JM, Larse JH 1977 HLA antigens in Graves' disease. Acta Endocrinol 86:510-516.
33. Farid NR, Stone E, Johnson G 1980 Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf ) 13:535-544.
34. Farid NR 1981 Graves' disease. In: Farid NR (ed) HLA in Endocrine and Metabolic Disorders. Academic Press, New York, pp 85-143.
35. Barlow ABT, Wheatcroft N, Watson P, Weetman AP 1996 Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol 44:73-77.
36. Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen ME, Curran PG, DeGroot LJ 1993 Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a caucasian population. J Clin Endocrinol Metab 76:1569-1574.
37. Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ 2000 Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet 95:432-437.
38. Todd JA, Bell JI, McDevitt HO 1987 HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604.
39. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y 2004 Arginine at position 74 of the HLA-DRb1 chain is associated with Graves' disease. Genes Immun 5:203-208.
40. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA, Todd JA, Gough SC 2005 Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 76:157-163.
41. Wucherpfennig KW 2001 Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr Opin Immunol 13:650-656.
42. Gebe JA, Swanson E, Kwok WW 2002 HLA class II peptide-binding and autoimmunity. Tissue Antigens 59:78-87.
43. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL 1995 Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 92:11935-11939.
44. Farid NR, Sampson L, Moens H, Barnard JM 1981 The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 17:265-268.
45. Moens H, Farid NR, Sampson L, Noel EP, Barnard JM 1978 Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med 299:133-134.
46. Tandon N, Zhang L, Weetman AP 1991 HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 34:383-386.
47. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y 2002 The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 57:81-88.
48. Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R 2001 Association of DRB1*04- DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11:171-175.
49. Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y 2005 Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 90:4904-4911.
50. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S 1994 The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922.
51. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC 1993 Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150:3671-3680.
52. Arpin C, Dechanet J, van Kooten C, Merville P, Grouard G, Briere F, Banchereau J, Liu YJ 1995 Generation of memory B cells and plasma cells in vitro. Science 268:720-722.
53. Ferrari S, Giliani S, Insalaco A, Al Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A 2001 Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98:12614-12619.
54. Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, Bhan AK, Geha RS 1994 CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 91:12135-12139.
55. van Kooten C, Banchereau J 1997 Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9:330-337.
56. Mohan C, Shi Y, Laman JD, Datta SK 1995 Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480.
57. Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC 2001 Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. J Immunol 166:6893-6898.
58. Chen CR, Aliesky HA, Guo J, Rapoport B, McLachlan SM 2006 Blockade of costimulation between T cells and antigen-presenting cells: an approach to suppress murine Graves' disease induced using thyrotropin receptor-expressing adenovirus. Thyroid 16:427-434.
59. Resetkova E, Kawai K, Enomoto T, Arreaza G, Togun R, Foy TM, Noelle RJ, Volpe R 1996 Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. Thyroid 6:267-273.
60. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1998 A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 63:1749-1756.
61. Tomer Y, Concepcion E, Greenberg DA 2002 A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12:1129-1135.
62. Pearce SH, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P 1999 Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease [letter]. Am J Hum Genet 65:1462-1465.
63. Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, Perros P, Pearce SH 2004 Role of the CD40 locus in Graves' disease. Thyroid 14:506-509.
64. Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, Zebracka J, Steinhof-Radwanska K, Hasse-Lazar K, Hiromatsu Y, Jarzab B, Bednarczuk T 2005 Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid 15:1119-1124.
65. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park DJ 2003 A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13:919-926.
66. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y 2006 Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves' disease in Japanese. Thyroid 16:443-446.
67. Mukai T, Hiromatsu Y, Fukutani T, Ichimura M, Kaku H, Miyake I, Yamada K 2005 A C/T polymorphism in the 5′ untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese. Endocr J 52:471-477.
68. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC 2004 A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin Endocrinol (Oxf) 61:269-272.
69. Tomer Y, Davies TF, Greenberg DA 2005 What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease? Clin Endocrinol (Oxf) 62:258.
70. Kozak M 1991 Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266:19867-19870.
71. Jacobson EM, Concepcion E, Oashi T, Tomer Y 2005 A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146:2684-2691.
72. Park JH, Chang HS, Park CS, Jang AS, Park BL, Rhim TY, Uh ST, Kim YH, Chung IY, Shin HD 2007 Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE. Am J Respir Crit Care Med 175:775-782.
73. Metcalfe RA, McIntosh RS, Marelli-Berg F, Lombardi G, Lechler R, Weetman AP 1998 Detection of CD40 on human thyroid follicular cells: analysis of expression and function. J Clin Endocrinol Metab 83:1268-1274.
74. Smith TJ, Sciaky D, Phipps RP, Jennings TA 1999 CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases. Thyroid 9:749-755.
75. Bottazzo GF, Pujol Borrell R, Hanafusa T, Feldmann M 1983 Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115-1119.
76. Jacobson EM, Huber AK, Akeno N, Sivak M, Li CW, Concepcion E, Ho K, Tomer Y 2007 A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun. Epub ahead of print.
77. Buck D, Kroner A, Rieckmann P, Maurer M, Wiendl H 2006 Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis. Tissue Antigens 68:335-338.
78. Teft WA, Kirchhof MG, Madrenas J 2006 A molecular perspective of CTLA-4 function. Annu Rev Immunol 24:65-97.
79. Wu Y, Guo Y, Huang A, Zheng P, Liu Y 1997 CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J Exp Med 185:1327-1335.
80. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH 1995 Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547.
81. Alegre ML, Noel PJ, Eisfelder BJ, Chuang E, Clark MR, Reiner SL, Thompson CB 1996 Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 157:4762-4770.
82. Sansom DM, Walker LS 2006 The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212:131-148.
83. Kristiansen OP, Larsen ZM, Pociot F 2000 CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 1:170-184.
84. Finck BK, Linsley PS, Wofsy D 1994 Treatment of murine lupus with CTLA4Ig. Science 265:1225-1227.
85. Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ 1995 Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest 96:987-993.
86. Nishikawa K, Linsley PS, Collins AB, Stamenkovic I, McCluskey RT, Andres G 1994 Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis. Eur J Immunol 24:1249-1254.
87. Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY, Fuchs E, Singh B, Thompson CB, Bluestone JA 1996 CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5:285-293.
88. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ 1995 CTLA-4 gene polymorphism associated with Graves' disease in a caucasian population. J Clin Endocrinol Metab 80:41-45.
89. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA 1996 The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5:1075-1080.
90. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K 1997 CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146.
91. Kotsa K, Watson PF, Weetman AP 1997 A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol 46:551-554.
92. Kouki T, Gardine CA, Yanagawa T, DeGroot LJ 2002 Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J Endocrinol Invest 25:208-213.
93. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511.
94. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y 2003 Analysis of the CTLA-4, CD28 and inducible co-stimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 4:586-593.
95. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA, Gough SC 2002 Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 12:3-6.
96. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K 1998 CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51:563-566.
97. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T 1997 CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7:843-846.
98. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC 1999 The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 84:2398-2401.
99. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW 2000 Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10:851-858.
100. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, Cho BY 2000 Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10:453-459.
101. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, Franklyn JA, Gough SC 2001 MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358:984-985.
102. Zaletel K, Krhin B, Gaberscek S, Pirnat E, Hojker S 2002 The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 12:373-376.
103. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SH 1999 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy [letter]. Lancet 354:743-744.
104. Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K 1997 Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 82:4130-4132.
105. Sale MM, Akamizu T, Howard TD, Yokota T, Nakao K, Mori T, Iwasaki H, Rich SS, Jennings-Gee JE, Yamada M, Bowden DW 1997 Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc Assoc Am Physicians 109:453-461.
106. Tomer Y, Greenberg DA, Barbesino G, Concepcion ES, Davies TF 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86:1687-1693.
107. Zaletel K, Krhin B, Gaberscek S, Hojker S 2006 Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis. Int J Immunogenet 33:87-91.
108. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43:55-68.
109. Tomer Y 2001 Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid 11:167-169.
110. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, SerranoRios M, Martinez Larrad MT, Teng WP, Park Y, Zhang ZX, Goldstein DR, Tao YW, Beaurain G, Bach JF, Huang HS, Luo DF, Zeidler A, Rotter JI, Yang MCK, Modilevsky T, Maclaren NK, She JX 1997 Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6:1275-1282.
111. Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P, Pearce SH 2000 Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab 85:688-691.
112. Downie-Doyle S, Bayat N, Rischmueller M, Lester S 2006 Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome. Arthritis Rheum 54:2434-2440.
113. Lee YH, Harley JB, Nath SK 2005 CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 116:361-367.
114. Huang D, Liu L, Noren K, Xia SQ, Trifunovic J, Pirskanen R, Lefvert AK 1998 Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 88:192-198.
115. Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C 2002 A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277:46478-46486.
116. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611.
117. Xu Y, Graves P, Tomer Y, Davies T 2002 CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell Immunol 215:133-140.
118. Chistiakov DA, Savost'anov KV, Turakulov RI, Efremov IA, Demurov LM 2006 Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease. Clin Immunol 118:233-242.
119. Wang XB, Zhao X, Giscombe R, Lefvert AK 2002 A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 3:233-234.
120. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J 2001 CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145-152.
121. Heward JM, Allahabadia A, Carr-Smith J, Daykin J, Cockram CS, Gordon CBAH, Franklyn JA, Gough SCL 1998 No evidence for allelic association of human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin Endocrinol 49:331-334.
122. Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, Eliasson M, Cilio CM, Holmberg D 2007 CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med Genet 8:3.
123. Takara M, Kouki T, DeGroot LJ 2003 CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease. Thyroid 13:1083-1089.
124. Wang XB, Kakoulidou M, Giscombe R, Qiu Q, Huang D, Pirskanen R, Lefvert AK 2002 Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol 130:224-232.
125. Shaw G, Kamen R 1986 A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
126. Butty V, Roy M, Sabeti P, Besse W, Benoist C, Mathis D 2007 Signatures of strong population differentiation shape extended haplotypes across the human CD28, CTLA4, and ICOS costimulatory genes. Proc Natl Acad Sci USA 104:570-575.
127. Cloutier JF, Veillette A 1999 Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189:111-121.
128. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK 2004 A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330-337.
129. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, Novitzke J, Williams AH, Gillett C, Rodine P, Graham RR, Ardlie KG, Gaffney PM, Moser KL, Petri M, Begovich AB, Gregersen PK, Behrens TW 2004 Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75:504-507.
130. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T 2004 A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36:337-338.
131. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tirgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA 2004 Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53:3020-3023.
132. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH 2004 The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89:5862-5865.
133. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK 2005 Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561-571.
134. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y 2005 The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 15:1115-1118.
135. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, Nika K, Tautz L, Tasken K, Cucca F, Mustelin T, Bottini N 2005 Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37:1317-1319.
136. Shulman S 1971 Thyroid antigens and autoimmunity. Adv Immunol 14:85-185.
137. Charreire J 1989 Immune mechanisms in autoimmune thyroiditis. Adv Immunol 46:263-334.
138. Kondo Y, Ui N 1961 Iodination of thyroglobulin by thyroid cellular fractions and the role of thyrotropic hormone. Biochim Biophys Acta 48:415-416.
139. Godelaine D, Spiro MJ, Spiro RG 1981 Processing of the carbohydrate units of thyroglobulin. J Biol Chem 256:10161-10168.
140. Consiglio E, Acquaviva AM, Formisano S, Liguoro D, Gallo A, Vittorio T, Santisteban P, De Luca M, Shifrin S, Yeh HJ, Kohn LD 1987 Characterization of phosphate residues on thyroglobulin. J Biol Chem 262:10304-10314.
141. Rose NR, Bonita R, Burek CL 2002 Iodine: an environmental trigger of thyroiditis. Autoimmun Rev 1:97-103.
142. Kong YC, McCormick DJ, Wan Q, Motte RW, Fuller BE, Giraldo AA, David CS 1995 Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination. J Immunol 155:5847-5854.
143. Wan Q, Motte RW, McCormick DJ, Fuller BE, Giraldo AA, David CS, Kong YM 1997 Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis: role of MHC class II. Clin Immunol Immunopathol 85:187-194.
144. Fenouillet E, Fayet G, Hovsepian S, Bahraoui EM, Ronin C 1986 Immunochemical evidence for a role of complex carbohydrate chains in thyroglobulin antigenicity. J Biol Chem 261:15153-15158.
145. Stafford EA, Rose NR 2000 Newer insights into the pathogenesis of experimental autoimmune thyroiditis. Int Rev Immunol 19:501-533.
146. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T 2001 Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 10:1379-1386.
147. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF 2002 Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 87:404-407.
148. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y 2003 Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci USA 100:15119-15124.
149. Collins JE, Heward JM, Carr-Smith J, Daykin J, Franklyn JA, Gough SCL 2003 Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab 88:5039-5042.
150. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y 2004 Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin Endocrinol (Oxf) 61:263-268.
151. Collins JE, Heward JM, Howson JM, Foxall H, Carr-Smith J, Franklyn JA, Gough SC 2004 Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J Clin Endocrinol Metab 89:6336-6339.
152. Robinson JH, Delvig AA 2002 Diversity in MHC class II antigen presentation. Immunology 105:252-262.
153. Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, Villanueva R, Tomer Y 2006 Possible interaction between HLA-DRβ1 and thyroglobulin variants in Graves' disease. Thyroid 16:351-355.
154. Tonacchera M, Pinchera A 2000 Thyrotropin receptor polymorphisms and thyroid diseases. J Clin Endocrinol Metab 85:2637-2639.
155. Cuddihy RM, Dutton CM, Bahn RS 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5:89-95.
156. Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA, Gough SC 1998 Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. Thyroid 8:777-780.
157. Kotsa KD, Watson PF, Weetman AP 1997 No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid 7:31-33.
158. Simanainen J, Kinch A, Westermark K, Winsa B, Bengtsson M, Schuppert F, Westermark B, Heldin NE 1999 Analysis of mutations in exon 1 of the human thyrotropin receptor gene: high frequency of the D36H and P52T polymorphic variants. Thyroid 9:7-11.
159. Kaczur V, Takacs M, Szalai C, Falus A, Nagy Z, Berencsi G, Balazs C 2000 Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet 27:17-23.
160. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV 2000 Complex association analysis of graves disease using a set of polymorphic markers. Mol Genet Metab 70:214-218.
161. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, Akamizu T 2005 Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 90:2898-2903.
162. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM, Wass JA, Wiersinga WM, Hegedus L, Brix T, Robinson BG, Hunt PJ, Weetman AP, Carey AH, Gough SC 2005 Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13:1223-1230.
163. Wucherpfennig KW 2003 MHC-linked susceptibility to type 1 diabetes: a structural perspective. Ann NY Acad Sci 1005:119-127.
164. Van Limbergen J, Russell RK, Nimmo ER, Ho GT, Arnott ID, Wilson DC, Satsangi J 2006 Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis 13:338-355.
165. Devlin SM, Yang H, Ippoliti A, Taylor KD, Landers CJ, Su X, Abreu MT, Papadakis KA, Vasiliauskas EA, Melmed GY, Fleshner PR, Mei L, Rotter JI, Targan SR 2007 NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology 132:576-586.
166. Sawai Y, DeGroot LJ 2000 Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab 85:1176-1179.